-
Jan 04, 2022
BRISBANE, Calif. --(BUSINESS WIRE)--Jan. 4, 2022-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will provide a corporate presentation at the H.C. Wainwright BIOCONNECT Virtual Conference on Monday, January 10 th at 7:00 a.m. Eastern Time .
Displaying 11 - 11 of 11